Phase 1b Study of Carfilzomib in Combination With Induction Chemotherapy in Children With Relapsed or Refractory Acute Lymphoblastic Leukemia
The purpose of the study is to determine the maximum tolerated dose and assess the safety,
tolerability and activity of carfilzomib, alone and in combination with induction
chemotherapy, in children with relapsed or refractory acute lymphoblastic leukemia (ALL).
View this trial on ClinicalTrials.gov
Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.
These resources are provided in partnership with the
Canadian Cancer Society